Alflutop - in modern symptom - modifying osteoarthritis therapy
- 作者: Drozdov V1, Shikh E1, Serebrova S1, Abrosimov A1, Starodubtsev A1
-
隶属关系:
- Clinical pharmacology and internal medicine propaedeutics of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Department of general medicine
- 期: 卷 91, 编号 5 (2019)
- 页面: 134-140
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33669
- DOI: https://doi.org/10.26442/00403660.2019.05.000169
- ID: 33669
如何引用文章
全文:
详细
作者简介
V Drozdov
Clinical pharmacology and internal medicine propaedeutics of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Department of general medicine
Email: vndrozdov@yandex.ru
д.м.н., проф., проф. каф. клинической фармакологии и пропедевтики внутренних болезней лечебного фак-та ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет) Moscow, Russia
E Shikh
Clinical pharmacology and internal medicine propaedeutics of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Department of general medicineд.м.н., проф., зав. каф. клинической фармакологии и пропедевтики внутренних болезней лечебного фак-та ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет) Moscow, Russia
S Serebrova
Clinical pharmacology and internal medicine propaedeutics of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Department of general medicineд.м.н., проф. каф. клинической фармакологии и пропедевтики внутренних болезней лечебного фак-та ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет) Moscow, Russia
A Abrosimov
Clinical pharmacology and internal medicine propaedeutics of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Department of general medicineк.м.н., доцент каф. клинической фармакологии и пропедевтики внутренних болезней лечебного фак-та ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет) Moscow, Russia
A Starodubtsev
Clinical pharmacology and internal medicine propaedeutics of I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Department of general medicineд.м.н., проф., проф. каф. клинической фармакологии и пропедевтики внутренних болезней лечебного фак-та ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России (Сеченовский Университет) Moscow, Russia
参考
- Noyszewski E.A, Wroblewski K, Dodge G.R, Kudchodkar S, Beers J, Sarma A.V, et al. Preferential incorporation of glucosamine into the galactosamine moieties of chondroitin sulfate in articular cartilage explants. Arthritis Rheum. 2001;44:1089-95. https://doi.org/10.1002/1529-0131(200105)44:5<1089::AID-ANR189>3.0.CO;2-9
- Bassleer C, Rovati L.C, Franchimont P. Glucosamine sulfate stimulates proteoglycan production in human chondrocytes in vitro. Osteoarthritis Cartilage. 1998;6:427-34. https://doi.org/10.1053/joca.1998.0146
- Piperno M, Reboul P, Helio Le, Graverand M.P, Peschard M.J, Annefeld M, Richard M, et al. Glucosamine sulfate modulates dysregulated activities of human osteoarthritic chondrocytes in vitro. Osteoarthritis Cartilage. 2000;8:207-12. https://doi.org/10.1053/joca.1999.0291
- Dodge G.R, Jimenez S.A. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3 synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage. 2003;11:424-32. https://doi.org/10.1016/s1063-4584(03)00052-9
- Mroz P.J, Silbert J.E. Use of 3H-glucosamine and 35S-sulfate with cultured human chondrocytes to determine the effect of glucosamine concentration on formation of chondroitin sulfate. Arthritis Rheum. 2004;50:3574-9. https://doi.org/10.1002/art.20609
- Biggee B.A, Blinn C.M, Mc Alindon T.E, Nuite M, Silbert J.E. Low levels of human serum glucosamine after ingestion of glucosamine sulfate relative to capability for peripheral effectiveness. Ann Rheum Dis. 2006;65:222-6. https://doi.org/10.1136/ard.2005.036368
- Varghese S, Theprungsirikul P, Sahani S, Hwang N, Yarema K.J, Elisseeff J.H. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthritis Cartilage. 2007;15:59-68. https://doi.org/10.1016/ j.joca.2006.06.008
- Gouze J.N, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J, et al. Interleukin-1beta down - regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1beta - mediated effects in rat chondrocytes. Arthritis Rheum. 2001;44:351-60. https://doi.org/10.1002/1529-0131(200102)44:2%3C351:: aid-anr53%3E3.0.co;2-m
- Chiusaroli R, Piepoli T, Zanelli T, Ballanti P, Lanza M, Rovati L.C, et al. Experimental pharmacology of glucosamine sulfate. Int J Rheumatol. 2011: 939265 [Epub]. https://doi.org/10.1155/2011/939265
- Imagawa K, de Andrés M.C, Hashimoto K, Pitt D, Itoi E, Goldring M.B, et al. The epigenetic effect of glucosamine and a nuclear factor - kappa B (NF-kB) inhibitor on primary human chondrocytes - implications for osteoarthritis. Biochem Biophys Res Commun. 2011;405:362-7. https://doi.org/10.1016/j.bbrc. 2011.01.007
- Maneiro E, Fernández Sueiro J, Lema D, de Toro F, Galdo F, Blanco F. Efecto del condroitín sulfato sobre la producción de óxido nítrico por los condrocitos humanos artrósicos. Rev Esp Reumatol. 2001;28:12-7. https://doi.org/10.39 89/mc.1961.v11.i103.1883
- Vergés J, Montell E, Martinez G, Heroux L, du Souich P. Chon - droitin sulfate reduces nuclear translocation factor NF-kappaB and does not modify the activation state of activating protein-1 (AP-1) (Abstract). Osteoarthritis Cartilage. 2004;12:194. https://doi.org/10.1016/s1063-4584(08)60572-5
- Jomphe C, Gabriac M, Hale T.M, Heroux L, Trudeau L.E, Deblois D, et al. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor - kappaB in interleukin-1beta - stimulated chondrocytes. Basic Clin Pharmacol Toxicol. 2008;102:59-65. https://doi.org/10.1111/j.1742-7843.2007.00158.x
- Caraglia M, Beninati S, Giuberti G, D’Alessandro A.M, Lentini A, Abbruzzese A, et al. Alternative therapy of earth elements increases the chondroprotective effects of chondroitin sulfate in mice. Exp Mol Med. 2005;37:476-81. https://doi.org/10.1038/emm.2005.58
- Bassleer C.T, Combal J.P, Bougaret S, Malaise M. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage. 1998;6:196e204. https://doi.org/10.1053/joca.199 8.0112
- Uebelhart D, Thonar E.J, Zhang J, Williams J.M. Protective effect of exogenous chondroitin 4,6-sulfate in the acute degradation of articular cartilage in the rabbit. Osteoarthritis Cartilage. 1998;6(Suppl A):6-13. https://doi.org/10.1016/ s1063-4584(98)80005-8
- Wang L, Wang J, Almqvist K.F, Veys E.M, Verbruggen G. Influence of polysulphated polysaccharides and hydrocortisone on the extracellular matrix metabolism of human articular chondrocytes in vitro. Clin Exp Rheumatol. 2002;20:669-76. https://doi.org/10.1016/s1063-4584(03)00168-7
- Orth M.W, Peters T.L, Hawkins J.N. Inhibition of articular cartilage degradation by glucosamine HCl and chondroitin sulphate. Equine Vet J Suppl. 2010;34:224-9. https://doi.org/10.1111/j.2042-3306.2002.tb05423.x
- Chan P.S, Caron J.P, Orth M.W. Effect of glucosamine and chondroitin sulfate on regulation of gene expression of proteolytic enzymes and their inhibitors in interleukin-1- challenged bovine articular cartilage explants. Am J Vet Res. 2005;66:1870-6. https://doi.org/10.2460/ajvr.2005.66.1870
- Chou M.M, Vergnolle N, Mc Dougall J.J, Wallace J.L, Marty S, Teskey V, et al. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin- 1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp Biol Med. 2005;230:255-62. https://doi.org/10.1177/153 537020523000405
- Monfort J, Nacher M, Montell E, Vila J, Verges J, Benito P. Chondroitin sulfate and hyaluronic acid (500e730 kDa) inhibit stromelysin-1 synthesis in human osteoarthritic chondrocytes. Drugs Exp Clin Res. 2005;31:71-6. https:// doi.org/10.1016/s1699-258x(05)72734-0
- Baici A, Bradamante P. Interaction between human leukocyte elastase and chondroitin sulfate. Chem Biol Interact. 1984;51:1-11. https://doi.org/10.10 16/0009-2797(84)90015-2
- Baici A, Lang A. Cathepsin B secretion by rabbit articular chondrocytes: modulation by cycloheximide and glycosami - noglycans. Cell Tissue Res. 1990;259:567-73. https://doi.org/10.1007/bf01740785
- Verbruggen G, Veys E.M. Influence of sulphated glycosamino - glycans upon proteoglycan metabolism of the synovial lining cells. Acta Rhumatol Belg. 1977;1:75-92.
- Nishikawa H, Mori I, Umemoto J. Influences of sulfated glycosaminoglycans on biosynthesis of hyaluronic acid in rabbit knee synovial membrane. Arch Biochem Biophys. 1985;240:146-53. https://doi.org/10.1016/0003-9861(85) 90017-7
- Nishikawa H, Mori I, Umemoto J. Glycosaminoglycan polysulfate - induced stimulation of hyaluronic acid synthesis in rabbit knee synovial membrane: involvement of binding protein and calcium ion. Arch Biochem Biophys. 1988;266:201-9. https://doi.org/10.1016/0003-9861(88)90251-2
- Chan P.S, Caron J.P, Rosa G.J, Orth M.W. Glucosamine and chondroitin sulfate regulate gene expression and synthesis of nitric oxide and prostaglandin E(2) in articular cartilage explants. Osteoarthritis Cartilage. 2005;13:387-94. https://doi.org/10.1016/j.joca.2005.01.003
- Chan P.S, Caron J.P, Orth M.W. Short - term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate. J Rheumatol. 2006;33:1329-40.
- Tat S.K, Pelletier J.P, Vergés J, Montell E, Lajeunesse D, Fahmi H, et al. Chondroitin and glucosamine sulfate in combination decrease the pro - resorptive properties of human osteoarthritis subchondral bone osteoblasts. Arthritis Res Ther. 2007;9:R117. https://doi.org/10.1186/ar2325
- Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005;64:669-81. https://doi.org/10. 1136/ard.2004.028886
- Zhang W, Moskowitz R.W, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence - based, expert consensus guidelines. Osteoarthritis Cartilage. 2008;16:137-62. https://doi.org/10.1016/j.joca.2008.04.019
- Zhang W, Moskowitz R.W, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15:981-1000. https://doi.org/10.1016/j.joca.20 08.04.019
- Zhang W, Nuki G, Moskowitz R.W, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18:476-99.
- Hochberg M.C, Altman R.D, April K.T, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64:465-74. https://doi.org/10.1002/acr.21596
- Mc Alindon T.E, Bannuru R.R, Sullivan M.C, et al. OARSI guidelines for the non - surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-88. https://doi.org/10.1016/ j.joca.2014.01.003
- Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richardy H, Beauchamp G, Laverty S. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride. Osteoarthritis and Cartilage. 2008;16:973-9. https://doi.org/10. 1016/j.joca.2008.01.006
- Persiani S, Rotini R, Trisolino G, Rovati L.C, Locatelli M, Paganini D, Antonioli D, Roda A. Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. OsteoArthritis and Cartilage. 2007;15:764-72. https://doi.org/10.1016/ j.joca.2007.01.019
- Biggee B.A, Blinn C.M, Mc Alindon T.E, Nuite M, Silbert J.E. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis. 2006;65:222-6. doi: 10.1136/ard.2005.036368
- Volpi N. Oral absorption and bioavailability of ichthyic origin chondroitin sulfate in healthy male volunteers. OsteoArthritis and Cartilage. 2003;11:433-41. https://doi.org/10.1016/s1063-4584(03)00051-7
- Laura Olariu, Brindusa Dumitriu, Diana Manuela Ene, Alexey Pavlov, Natalya Pyatigorskaya, Natalia Rosoiu. Alflutop Modulates “In Vitro” Relevant Mechanisms of Osteoarthritic Pathology. Annals Series on Bio - logical Sciences. 2017 Academy of Romanian Scientists. 2017;6(1):82-99. ISSN 2285 - 4177
- Laura Olariu, Brindusa Dumitriu, Emilia Buse, Natalia Rosoiu. The ”In Vitro” Effect Of Alflutop Product On Some Extracellular Signaling Factors Involved In The Osteoarthicular Pathology Inflammation The ”In Vitro” Effect Of Alflutop® Product On Some Extracellular Signaling Factors Involved In The Osteoarthicular Pathology Inflammation. Academy of Romanian Scientists. Annals Series on Biological Sciences. 2015;4(2):7-18. ISSN 2285 - 4177 Online Edition; Original Paper, Received for publication, September, 15, 2015. Accepted, December, 01, 2015
- Алексеева Л.И., Шарапова Е.П., Таскина Е.А. и др. Многоцентровое слепое рандомизированное плацебоконтролируемое исследование симптом - и структурно - модифицирующего действия препарата алфлутоп у больных остеоартрозом коленных суставов. Сообщение 1 - Оценка симптом - модифицирующего действия препарата. Научно - практическая ревматология. 2013;51(5):532-8. https://doi.org/10.14412/1995-4484-2013-1545
- Hawkey C.J. Cyclooxygenase inhibition: between the devil and the deep blue sea. GUT. 2002;50(suppl.3):1125-30. https://doi.org/10.1136/gut.50. suppl_3.iii25
- Taha A.S, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti - inflammatory drugs. N Engl J Med. 1996;334:1435-9.
- Agrawal N.M, Van Kerchkhove H, Erhardt L.J, Geis G.S. Dig Dis Sci. 1995;40:1125-31. https://doi.org/10.1007/bf02064210
- Labeling Guidance Diclofenac Sodium February 1995; www.fda.gov (accessed 8/3/01) Traversa G, et al. Cohort study of hepatotoxicity associated with nimesulide and other non - steroidal anti - inflammatory drugs. BMJ. 2003;327:18-22.
- Trechot P, et al. Incidence of hepatitis induced by non - steroidal anti - inflammatory drugs (NSAID). Ann Rheum Dis. 1996 Dec;55(12):936.
- Boelsterli U. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf. 2002;25:633-48.
- Kumar S. Drug linked to child deaths is still available in India. BMJ. 2003;326:70.
- Светлова М.С., Игнатьев В.К. Применение алфлутопа в лечении больных остеоартрозом. Клиническая медицина. 2004;6:52-5.
- Дроздов В.Н., Коломеец Е.В. Применение Алфлутопа у больных остеоартрозом с гастропатией, развившейся на фоне лечения НПВП. Фарматека. 2005;20:125-8.
- Emilia Buse, Brandusa Dumitriu, Laura Olariu, Diana Ene, Mihai Bojinca, Toma Papacocea. Cellular and molecular activity of a standardized small sea fish extract in an experimental model of primary human cartilage cells. Roman J of Rheumatol. 2018;27(1):23-31.
- Laura Olariu, Brindusa Dumitriu, Luiza Craciun, Emilia Buse, Natalia Rosoiu, Mihai Bojinca, Toma Papacocea. The In Vitro Influence of A Pharmaceutically Active Small Sea Fish Extract on Apoptosis and Proliferation Mechanisms Amplified by Inflammatory Conditions. Manuscript received: November 2017. FARMACIA. 2018;66(3).